Minimising the toxicities of targeted therapies

Date 07 October 2016
Event ESMO 2016 Congress
Session New developments in the management of ER-positive metastatic breast cancer
Topics Cytotoxic agents
Complications/Toxicities of treatment
Breast Cancer
Therapy
Biological therapy
Presenter Thomas Bachelot
Authors T. Bachelot
  • Medical Oncology, Centre Leon Berard, 69373 - Lyon/FR